Abstract
Skin is composed of major layers, namely a superficial epidermis and a deeper dermis. The color of skin is influenced by a number of pigments, including melanin, which is produced by cells called melanocytes. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal. A number of more noticeable disorders, namely albinism and vitiligo, affect the appearance of the skin and its accessory organs. Vitiligo is associated with significant psycho-social morbidity and a major effect on quality of life. Topical steroids, calcineurin inhibitors, phototherapy and surgery are the most common treatments for melanoma. However, there are many patients who do not respond to any of these modalities. The transplantation of cultured or non-cultured melanocyte is the most important treatment for hypopigmentory disorders. This study aims at reviewing the history of melanocyte cultivation, and evaluating the effectiveness of transplantation of cultured cells. For this purpose, the authors examined the initial process of isolation, characterization, and transplantation of epidermal cells. This review, thus, summarizes the current understanding of the cutaneous pigmentary system from the start of synthesis in the pigment cells, along with the response of repigmentation. During the production of melanin, melanosomes are transferred to neighboring keratinocyte in order to form perinuclear melanin caps. The objective of this review is to analyze the melanocytes transplantation in the last century to date, and explore the methods epidermal cells can increase pigmentation in hypo-pigmented areas in skin disorders. Moreover, the focus is on the story of the melanocyte back to 1950s. In addition, prior systemic therapy was associated with a significant increase, based on combined additional therapy, achieving desired results and improved outcomes. Despite the short study of a long way of melanocyte assessment and following up patient treatment, results of the all reports confirmed the efficacy of the method used in the treatment of stable vitiligo patients, who did not respond to the common algorithms of non-invasive treatments.
Similar content being viewed by others
References
Adini I, Ghosh K, Adini A, Chi ZL, Yoshimura T, Benny O, Connor KM, Rogers MS, Bazinet L, Birsner AE, Bielenberg DR, D’Amato RJ (2014) Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment. J Clin Investig 124:425–436
Al-Hadidi N, Griffith JL, Al-Jamal MS, Hamzavi I (2015) Role of recipient-site preparation techniques and post-operative wound dressing in the surgical management of vitiligo. J Cutan Aesthet Surg 8:79–87
Alsubait N, Mulekar S, Al Issa A (2015) Failure of non-cultured melanocyte–keratinocyte transplantation in periungual vitiligo: a case report. J Dermatol Dermatol Surg 19:123–125
Aramwit P, Luplertlop N, Kanjanapruthipong T, Ampawong S (2018) Effect of urea-extracted sericin on melanogenesis: potential applications in post-inflammatory hyperpigmentation. Biol Res 51:54
Azzopardi JG, Eusebi V (1977) Melanocyte colonization and pigmentation of breast carcinoma. Histopathology 1:21–30
Bajouri A, Orouji Z, Taghiabadi E, Nazari A, Shahbazi A, Fallah N, Mohammadi P, Rezvani M, Jouyandeh Z, Vaezirad F, Khalajasadi Z, Ghasemi M, Fanni A, Haji Hosseinali S, Alizadeh A, Baharvand H, Shafieyan S, Aghdami N (2020) Long-term follow-up of autologous fibroblast transplantation for facial contour deformities, a non-randomized phase IIa clinical trial. Cell J 22:75–84
Bashash DD, Safa M, Shahbazi A, Mohammadian M, Shah-Mohammad N (2012) Apoptotic effect of milk thistle extract on human breast cancer MCF-7 cell. Complement Med J 2:85–95
Bassiouny D, Esmat S (2018) Autologous non-cultured melanocyte-keratinocyte transplantation in the treatment of vitiligo: patient selection and perspectives. Clin Cosmet Investig Dermatol 11:521–540
Bellingham CJM, Young AC, Brandt G, Brand EH (1960) Calibration of rapid gas analyzers with a mixing chamber. https://doi.org/10.1152/jappl.1969.27.1.112
Bennett DC (2003) Human melanocyte senescence and melanoma susceptibility genes. Oncogene 22:3063–3069
Bennett DC, Cooper PJ, Dexter TJ, Devlin LM, Heasman J, Nester B (1989) Cloned mouse melanocyte lines carrying the germline mutations albino and brown: complementation in culture. Development 105:379–385
Bentley NJ, Eisen T, Goding CR (1994) Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol Cell Biol 14:7996–8006
Benzekri L, Gauthier Y (2017) The first transepidermal transplantation of non-cultured epidermal suspension using a dermarolling system in vitiligo: a sequential histological and clinical study. Pigment Cell Melanoma Res 30:493–497
Bergqvist C, Ezzedine K (2020) Vitiligo: a review. Dermatology 236:571–592
Bergstresser PR, Pariser RJ, Taylor JR (1978) Counting and sizing of epidermal cells in normal human skin. J Investig Dermatol 70:280–284
Chen YF, Yang PY, Hu DN, Kuo FS, Hung CS, Hung CM (2004) Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases. J Am Acad Dermatol 51:68–74
Cruickshank, R, (1960) World health organization & inter-regional smallpox conference. https://apps.who.int/iris/handle/10665/67152
Dillon AB, Sideris A, Hadi A, Elbuluk N (2017) Advances in vitiligo: an update on medical and surgical treatments. J Clin Aesthet Dermatol 10:15–28
Eisinger M, Marko O (1982) Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc Natl Acad USA 79(6):2018–2022. https://doi.org/10.1073/pnas.79.6.2018
El-Zawahry BM, Zaki NS, Bassiouny DA, Sobhi RM, Zaghloul A, Khorshied MM, Gouda HM (2011) Autologous melanocyte–keratinocyte suspension in the treatment of vitiligo. J Eur Acad Dermatol Venereol 25:215–220
Fabrikant J, Touloei K, Brown SM (2013) A review and update on melanocyte stimulating hormone therapy: afamelanotide. J Drugs Dermatol JDD 12:775–779
Falabella R (2009) Vitiligo and the melanocyte reservoir. Indian J Dermatol 54:313–318
Funan Hu (1956): The roller tube tissue culture technic in the evaluation of the primary irritancy producing capacity of topical medicaments and chemicals. https://doi.org/10.1038/jid.1956.3
Gauthier Y, Surleve-Bazeille JE (1992) Autologous grafting with noncultured melanocytes: a simplified method for treatment of depigmented lesions. J Am Acad Dermatol 26:191–194
Godwin LS, Castle JT, Kohli JS, Goff PS, Cairney CJ, Keith WN, Sviderskaya EV, Bennett DC (2014) Isolation, culture, and transfection of melanocytes. Curr Protoc Cell Biol 63:1–20
Gunjan Verma (2015) Evaluation of repigmentation with cultured melanocyte transplantation (CMT) Compared with non-cultured epidermal cell transplantation in vitiligo at 12th week reveals better repigmentation with CMT. J Invest Dermatol 135(10):2533–2535. https://doi.org/10.1038/jid.2015.178
Hu F, Cardell RR Jr (1962) Observations on the ultrastructure of human skin. Henry Ford Hosp Med Bull 10:63–87
Huggins RH, Henderson MD, Mulekar SV, Ozog DM, Kerr HA, Jabobsen G, Lim HW, Hamzavi IH (2012) Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States. J Am Acad Dermatol 66:785–793
Ikeda Y, Wada A, Hasegawa T, Yokota M, Koike M, Ikeda S (2021) Melanocyte progenitor cells reside in human subcutaneous adipose tissue. PLoS ONE 16:e0256622
Kaufmann R, Greiner D, Kippenberger S, Bernd A (1998) Grafting of in vitro cultured melanocytes onto laser-ablated lesions in vitiligo. Acta Derm Venereol 78:136–138
Khodadadi L, Shafieyan S, Sotoudeh M, Dizaj AV, Shahverdi A, Aghdami N, Baharvand H (2010) Intraepidermal injection of dissociated epidermal cell suspension improves vitiligo. Arch Dermatol Res 302:593–599
Lerner AB, Halaban R, Klaus SN, Moellmann GE (1987) Transplantation of human melanocytes. J Investig Dermatol 89:219–224
Lin SJ, Jee SH, Hsiao WC, Yu HS, Tsai TF, Chen JS, Hsu CJ, Young TH (2006) Enhanced cell survival of melanocyte spheroids in serum starvation condition. Biomaterials 27:1462–1469
Liu LP, Li YM, Guo NN, Li S, Ma X, Zhang YX, Gao Y, Huang JL, Zheng DX, Wang LY, Xu H, Hui L, Zheng YW (2019) Therapeutic potential of patient iPSC-derived imelanocytes in autologous transplantation. Cell Rep 27:455–466
Madireddy S, Crane JS (2021) Hypopigmented macules. StatPearls, Treasure Island
Mysore V, Salim T (2009) Cellular grafts in management of leucoderma. Indian J Dermatol 54:142–149
Navarro-Fernandez I, Gonzalez-Vela C, Gomez-Fernandez C, Duran-Vian C, Reguero L, Gonzalez-Lopez M (2021) Vitiligo-like depigmentation in a patient undergoing treatment with nivolumab for advanced renal-cell carcinoma. Acta Dermatovenerol Croat 291:54–55
Nielsen HI, Don P (1984) Culture of normal adult human melanocytes. Br J Dermatol 110(5):569–580. https://doi.org/10.1111/j.1365-2133.1984.tb04680.x
Ohbayashi N, Fukuda M (2020) Recent advances in understanding the molecular basis of melanogenesis in melanocytes. F1000Res 9:608
Omeljaniuk RJ, Tonon MC, Peter RE (1989) Dopamine inhibition of gonadotropin and alpha-melanocyte-stimulating hormone release in vitro from the pituitary of the goldfish (Carassius auratus). Gen Comp Endocrinol 74:451–467
Orouji Z, Bajouri A, Ghasemi M, Mohammadi P, Fallah N, Shahbazi A, Rezvani M, Vaezirad F, Khalajasadi Z, Alizadeh A, Taghiabadi E, Dashtbozorgi S, Aghdami R, Hosseini SE, Bahahrvand H, Shafieyan S, Aghdami N (2018) A single-arm open-label clinical trial of autologous epidermal cell transplantation for stable vitiligo: a 30-month follow-up. J Dermatol Sci 89:52–59
Ostojic J, Yoon YS, Sonntag T, Nguyen B, Vaughan JM, Shokhirev M, Montminy M (2021) Transcriptional co-activator regulates melanocyte differentiation and oncogenesis by integrating cAMP and MAPK/ERK pathways. Cell Rep 35:109136
Pandya V, Parmar KS, Shah BJ, Bilimoria FE (2005) A study of autologous melanocyte transfer in treatment of stable vitiligo. Indian J Dermatol Venereol Leprol 71:393–397
Pomerat (1950) The effect of ascitic fluid and of blood serum on the outgrowth of epidermal cells from the human skin in tissue culture. O ULLOA-GREGORI et al. Tex Rep Biol Med. 1950
Popovic D, Popovic B, Seman S, Labudovic D, Lasica R, Jakovljevic DG, Arena R, Damjanovic SS (2020) The alpha-melanocyte stimulating hormone is related to heart rate during exercise recovery. Heliyon 6:e05380
Rao A, Gupta S, Dinda AK, Sharma A, Sharma VK, Kumar G, Mitra DK, Prashant CK, Singh G (2012) Study of clinical, biochemical and immunological factors determining stability of disease in patients with generalized vitiligo undergoing melanocyte transplantation. Br J Dermatol 166:1230–1236
Shahbazi A, Safa M, Alikarami F, Kargozar S, Asadi MH, Joghataei MT, Soleimani M (2016) Rapid induction of neural differentiation in human umbilical cord matrix mesenchymal stem cells by cAMP-elevating agents. Int J Mol Cell Med 5:167–177
Shahbazi A, Naseh MH, Habibi M, Shirazi R, Choobineh H, Akrami SM (2020) One-year follow-up of vitiligo patients treated with autologous non-cultured melanocytes. Iran Red Crescent Med J. https://doi.org/10.5812/ircmj.81990
Silpa-Archa N, Griffith JL, Huggins RH, Henderson MD, Kerr HA, Jacobsen G, Mulekar SV, Lim HW, Hamzavi IH (2017) Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas. J Am Acad Dermatol 77:318–327
Skowron F, Bensaid B, Balme B, Depaepe L, Kanitakis J, Nosbaum A, Maucort-Boulch D, Berard F, D’Incan M, Kardaun SH, Nicolas JF (2015) Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases. J Eur Acad Dermatol Venereol 29:2199–2205
Sono M, Roach MP, Coulter ED, Dawson JH (1996) Heme-containing oxygenases. Chem Rev 96:2841–2888
Stromberg S, Bjorklund MG, Asplund A, Rimini R, Lundeberg J, Nilsson P, Ponten F, Olsson MJ (2008) Transcriptional profiling of melanocytes from patients with vitiligo vulgaris. Pigment Cell Melanoma Res 21:162–171
Suvanprakorn P, Dee-Ananlap S, Pongsomboon C, Klaus SN (1985) Melanocyte autologous grafting for treatment of leukoderma. J Am Acad Dermatol 13:968–974
Tadokoro R, Shikaya Y, Takahashi Y (2019) Wide coverage of the body surface by melanocyte-mediated skin pigmentation. Dev Biol 449:83–89
Tang J, Li Q, Cheng B, Jing L (2014) Primary culture of human face skin melanocytes for the study of hyperpigmentation. Cytotechnology 66:891–898
Tham HL, Linder KE, Olivry T (2019) Autoimmune diseases affecting skin melanocytes in dogs, cats and horses: vitiligo and the uveodermatological syndrome: a comprehensive review. BMC Vet Res 15:251
Tsatmali M, Ancans J, Thody AJ (2002) Melanocyte function and its control by melanocortin peptides. J Histochem Cytochem 50:125–133
Wang Y, Tissot M, Rolin G, Muret P, Robin S, Berthon JY, He L, Humbert P, Viennet C (2018) Development and validation of a simple method for the extraction of human skin melanocytes. Cytotechnology 70:1167–1176
Wilkins LM, Szabo G (1981) The establishment of pure mammalian epidermal melanocyte cultures through growth in high levels of mycostatin. Arch Dermatolog Res 270:483–486
Wilkins L, Gilchrest BA, Szabo G, Weinstein R, Maciag T (1985) The stimulation of normal human melanocyte proliferation in vitro by melanocyte growth factor from bovine brain. J Cell Physiol 122:350–361
Zhong S, Wu Y, Soo-Mi A, Zhao J, Wang K, Yang S, Jae-Ho Y, Zhu X (2006) Depigmentation of melanocytes by the treatment of extracts from traditional Chinese herbs: a cell culture assay. Biol Pharm Bull 29:1947–1951
Zhu MC, Ma HY, Zhan Z, Liu CG, Luo W, Zhao G (2017) Detection of auto antibodies and transplantation of cultured autologous melanocytes for the treatment of vitiligo. Exp Ther Med 13:23–28
Funding
Funding was provided by School of Biology, Royan stem cell institute, University College of Science, Enghelab St. University of Tehran, Tehran, Iran (Grant No. 01).
Author information
Authors and Affiliations
Contributions
AS contributed to the study design, data collection, and writing the manuscript. SJZ contributed to data, patient evaluation and clinical data collection. Authors contributed in interpretation of the results and final preparation of the study design, data collection, writing the manuscript and financing the project.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Shahbazi, A., Zargar, S.J., Aghdami, N. et al. The story of melanocyte: a long way from bench to bedside. Cell Tissue Bank 25, 143–157 (2024). https://doi.org/10.1007/s10561-023-10081-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-023-10081-5